DUSTIN JONES: Open Payments
NPI 1083274724 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 63 payments from 21 companies in 2025. Trend: 2023 $306 · 2024 $894 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $201 |
| ABBVIE INC. | 8 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $151 |
| Lilly USA, LLC | 6 | $100 |
| Phathom Pharmaceuticals, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Astellas Pharma US Inc | 3 | $68 |
| Corium, LLC | 3 | $54 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| PFIZER INC. | 3 | $44 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, VOQUEZNA, REXULTI, Veozah, FARXIGA, Azstarys.
Industry payments across UT — which companies pay providers there.
